Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2015 Aug 28;150(5):1254–1260. doi: 10.1016/j.jtcvs.2015.08.071

Table 1.

Patient demographics

Demographics Readmit
n (%)
No Readmit
n (%)
p-value
Age
  65–69 110 (34%) 422 (34%) 0.916
  70–74 102 (32%) 410 (34%)
  75–79 71 (22%) 249 (20%)
  80–84 24 (8%) 119 (10%)
  85+ 12 (4%) 24 (2%)
Sex
  Female 71 (22%) 228 (19%) 0.726
Year of Diagnosis
  2000–2001 57 (18%) 219 (18%) 0.983
  2002–2003 59 (18%) 241 (20%)
  2004–2005 74 (23%) 295 (24%)
  2006–2007 65 (20%) 258 (21%)
  2008–2009 64 (20%) 211 (17%)
Tumor Stage
  0 10 (3%) 36 (3%) 0.990
  I 99 (32%) 412 (34%)
  II 124 (40%) 484 (40%)
  III 55 (18%) 196 (16%)
  IV 22 (7%) 71 (6%)
Comorbidities
  Induction chemotherapy 137 (43%) 445 (36%) 0.032
  COPD 41 (13%) 98 (8%) 0.011
  Diabetes 32 (10%) 167 (14%) 0.092
  Congestive heart failure 7 (2%) 34 (3%) 0.697
  Myocardial infarction 5 (2%) 10 (1%) 0.212
  Peripheral vascular disease 8 (3%) 18 (1%) 0.220

COPD: Chronic obstructive pulmonary disease